What is Clarium?
Founded in 2020, Clarium is at the forefront of revolutionizing the healthcare supply chain management sector. Its proprietary AI platform, Astra OS, provides health systems such as Yale New Haven Health, Stanford, and Geisinger with unified data, actionable insights, and automated workflows. By leveraging advanced technology, Clarium empowers leading health systems to achieve greater efficiency and cost-effectiveness in their supply chain operations, addressing critical needs in a complex industry.
How much funding has Clarium raised?
Clarium has raised a total of $37.5M across 2 funding rounds:
Other Financing Round
$10.5M
Series A
$27M
Other Financing Round (2024): $10.5M with participation from Kaiser Permanente Ventures, General Catalyst, and Yale New Haven Health
Series A (2025): $27M led by Texas Medical Center, AlleyCorp companies, 1984 Ventures, General Catalyst, and Kaiser Permanente
Key Investors in Clarium
Texas Medical Center
Texas Medical Center (TMC) is a prominent medical community in Houston, Texas, known for its extensive medical services, life science research, and fostering cross-institutional collaboration within the healthcare ecosystem.
AlleyCorp companies
AlleyCorp is an incubator and investor focused on building and supporting transformative businesses, comprising tech pioneers and entrepreneurs dedicated to creating impactful solutions across various sectors.
General Catalyst
General Catalyst is a venture capital firm that strategically backs entrepreneurs and management teams with ambitious visions, leveraging deep sector expertise to accelerate growth and build enduring enterprises in technology, healthcare, and other key industries.
What's next for Clarium?
With its recent major strategic investment and substantial total capital raised, Clarium is well-positioned for its next phase of growth. The company is likely to focus on expanding its platform's capabilities, enhancing its AI-driven insights, and broadening its client base within the healthcare sector. This significant backing suggests a strategic push towards scaling operations, further solidifying its market position as a leader in healthcare supply chain technology and innovation.
See full Clarium company page
